SLCO1B1 and myopathy: It can be estimated by using genetic frequency data from Bank et al. [38], that of 42 residents using statins (Table 3), 10 and 1 residents would have either intermediate or low function of SLCO1B1, respectively, and potentially be at risk for statin induced myopathies.